Artrya seeks ASX quotation for 500,000 new ordinary shares

Artrya Limited ( (AU:AYA) ) has shared an update.

Artrya Limited has applied for quotation on the ASX of 500,000 new ordinary fully paid shares, with an issue date of 14 April 2026 under its existing ticker AYA. The securities arise from the exercise or conversion of options or other convertible securities, representing a standard capital markets transaction that marginally increases the company’s free float and listed share base.

The application signals ongoing utilisation of equity-based instruments within Artrya’s capital structure, potentially reflecting incentives or prior financing arrangements now crystallising into ordinary equity. For existing shareholders, the move introduces limited dilution but may modestly improve liquidity in the stock by expanding the number of quoted shares on issue.

The most recent analyst rating on (AU:AYA) stock is a Buy with a A$6.27 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.

More about Artrya Limited

Artrya Limited, listed on the ASX under the code AYA, operates in the medical technology sector, though this filing provides only corporate and capital markets information. The company is identified by Australian Company Number 624005741 and is pursuing routine quotation of its equity securities on the Australian Securities Exchange.

Average Trading Volume: 511,635

Technical Sentiment Signal: Buy

Current Market Cap: A$621.3M

See more data about AYA stock on TipRanks’ Stock Analysis page.